Institutional Ownership Cytokinetics Inc (CYTK)
This table provides information about the institutional ownership of Cytokinetics Inc (CYTK). We have compiled data on the 397 institutions that hold shares in the stock, with a total of 122 Million shares, which have been reported (via 13F filing form) to have a value of $5.25 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,672,779
shares
|
$641 Million
0.02% of portfolio
|
Q2 2024
Added 18.19%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
11,915,821
shares
|
$521 Million
0.01% of portfolio
|
Q4 2024
Added 1.31%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
10,752,123
shares
|
$470 Million
0.31% of portfolio
|
Q4 2024
Added 10.96%
|
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
7,888,697
shares
|
$345 Million
0.07% of portfolio
|
Q4 2024
Added 1.46%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,167,340
shares
|
$269 Million
0.01% of portfolio
|
Q4 2024
Reduced 4.51%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,841,338
shares
|
$124 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.25%
|
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,721,158
shares
|
$119 Million
2.09% of portfolio
|
Q2 2024
Added 7.77%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,625,081
shares
|
$115 Million
0.01% of portfolio
|
Q4 2024
Reduced 17.06%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
2,500,000
shares
|
$109 Million
5.18% of portfolio
|
Q4 2024
Added 296.88%
|
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,350,000
shares
|
$103 Million
6.55% of portfolio
|
Q4 2024
Added 56.67%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,252,206
shares
|
$98.4 Million
0.09% of portfolio
|
Q2 2023
Reduced 0.8%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
2,196,721
shares
|
$96 Million
0.64% of portfolio
|
Q4 2024
Reduced 6.04%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
2,153,313
shares
|
$94.1 Million
0.13% of portfolio
|
Q4 2024
Added 14.92%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
1,911,999
shares
|
$83.5 Million
0.1% of portfolio
|
Q4 2024
Reduced 8.45%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,618,402
shares
|
$70.7 Million
0.01% of portfolio
|
Q4 2024
Added 31.05%
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
1,595,324
shares
|
$69.7 Million
0.03% of portfolio
|
Q4 2024
Reduced 3.95%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
1,584,005
shares
|
$69.2 Million
2.02% of portfolio
|
Q4 2024
Added 106.54%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,471,489
shares
|
$64.3 Million
0.01% of portfolio
|
Q4 2024
Added 10.67%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,371,645
shares
|
$59.9 Million
0.01% of portfolio
|
Q4 2024
Added 46.36%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,335,189
shares
|
$58.3 Million
0.01% of portfolio
|
Q4 2024
Added 1.04%
|
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,312,000
shares
|
$57.3 Million
0.87% of portfolio
|
Q4 2024
Reduced 30.82%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
Feb 11, 2025 Q4 2024 |
1,279,990
shares
|
$55.9 Million
0.28% of portfolio
|
Q4 2024
Added 5.53%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,252,988
shares
|
$54.7 Million
0.0% of portfolio
|
Q4 2024
Added 7.24%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,205,431
shares
|
$52.7 Million
0.01% of portfolio
|
Q4 2024
Added 1.74%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,201,999
shares
|
$52.5 Million
0.01% of portfolio
|
Q4 2024
Added 283.34%
|